Hbm Biocapital Ii Lp - Net Worth and Insider Trading

Hbm Biocapital Ii Lp Net Worth

The estimated net worth of Hbm Biocapital Ii Lp is at least $0 dollars as of 2024-12-28. Hbm Biocapital Ii Lp is the 10% Owner of Allena Pharmaceuticals Inc and owns about 1,638,330 shares of Allena Pharmaceuticals Inc (ALNAQ) stock worth over $0. Details can be seen in Hbm Biocapital Ii Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hbm Biocapital Ii Lp has not made any transactions after 2017-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hbm Biocapital Ii Lp

To

Hbm Biocapital Ii Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hbm Biocapital Ii Lp owns 1 companies in total, including Allena Pharmaceuticals Inc (ALNAQ) .

Click here to see the complete history of Hbm Biocapital Ii Lp’s form 4 insider trades.

Insider Ownership Summary of Hbm Biocapital Ii Lp

Ticker Comapny Transaction Date Type of Owner
ALNAQ Allena Pharmaceuticals Inc 2017-11-06 10 percent owner

Hbm Biocapital Ii Lp Latest Holdings Summary

Hbm Biocapital Ii Lp currently owns a total of 1 stock. Hbm Biocapital Ii Lp owns 1,638,330 shares of Allena Pharmaceuticals Inc (ALNAQ) as of November 6, 2017, with a value of $0.

Latest Holdings of Hbm Biocapital Ii Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNAQ Allena Pharmaceuticals Inc 2017-11-06 1,638,330 0.00 0

Holding Weightings of Hbm Biocapital Ii Lp


Hbm Biocapital Ii Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Hbm Biocapital Ii Lp has made a total of 0 transactions in Allena Pharmaceuticals Inc (ALNAQ) over the past 5 years. The most-recent trade in Allena Pharmaceuticals Inc is the acquisition of 71,428 shares on November 6, 2017, which cost Hbm Biocapital Ii Lp around $999,992.

Insider Trading History of Hbm Biocapital Ii Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hbm Biocapital Ii Lp Trading Performance

GuruFocus tracks the stock performance after each of Hbm Biocapital Ii Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hbm Biocapital Ii Lp is -24.24%. GuruFocus also compares Hbm Biocapital Ii Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hbm Biocapital Ii Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hbm Biocapital Ii Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hbm Biocapital Ii Lp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 39.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 38.03 LIMIT LIMIT LIMIT LIMIT LIMIT

Hbm Biocapital Ii Lp Ownership Network

Ownership Network List of Hbm Biocapital Ii Lp

No Data

Ownership Network Relation of Hbm Biocapital Ii Lp

Insider Network Chart

Hbm Biocapital Ii Lp Owned Company Details

What does Allena Pharmaceuticals Inc do?

Who are the key executives at Allena Pharmaceuticals Inc?

Hbm Biocapital Ii Lp is the 10 percent owner of Allena Pharmaceuticals Inc. Other key executives at Allena Pharmaceuticals Inc include See Remarks Louis Md Brenner , Chief Financial Officer Richard D Katz , and Chief Financial Officer Edward Wholihan .

Allena Pharmaceuticals Inc (ALNAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Allena Pharmaceuticals Inc (ALNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allena Pharmaceuticals Inc (ALNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allena Pharmaceuticals Inc (ALNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allena Pharmaceuticals Inc Insider Transactions

No Available Data

Hbm Biocapital Ii Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Hbm Biocapital Ii Lp. You might contact Hbm Biocapital Ii Lp via mailing address: 11-15 Seaton Place, St. Helier Y9 Je4 0qh.

Discussions on Hbm Biocapital Ii Lp

No discussions yet.